FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
-4.94%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$662M
AUM Growth
+$662M
(-8.2%)
Cap. Flow
-$21.6M
Cap. Flow
% of AUM
-3.27%
Top 10 Holdings %
Top 10 Hldgs %
49.89%
Holding
81
New
8
Increased
13
Reduced
33
Closed
10
Top Buys
| 1 |
Insmed
INSM
|
$22.8M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$20.5M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$13.9M |
| 4 |
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
|
$10.7M |
| 5 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$9.63M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$56.2M |
| 2 |
Nektar Therapeutics
NKTR
|
$25.4M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$14.1M |
| 4 |
Viatris
VTRS
|
$11M |
| 5 |
MODN
MODEL N, INC.
MODN
|
$5.79M |
Sector Composition
| 1 | Healthcare | 72.38% |
| 2 | Communication Services | 8.27% |
| 3 | Industrials | 1.62% |
| 4 | Energy | 0.92% |
| 5 | Financials | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXFD
1
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $61.9M | 9.35% | 3,719,291 +578,944 | +18% | +$9.63M |
|
|
MODN
2
DELISTED
MODEL N, INC.
MODN
| $54.7M | 8.27% | 1,970,044 -208,476 | -10% | -$5.79M |
|
3
Omnicell
OMCL
$1.5B
| $32.9M | 4.98% | 455,737 +124,275 | +37% | +$8.98M |
|
4
KORU Medical Systems
KRMD
$195M
| $28.4M | 4.29% | 7,180,017 +295,817 | +4% | +$1.17M |
|
|
MYOK
5
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $27.8M | 4.21% | 533,944 -4,055 | -0.8% | -$211K |
|
6
AtriCure
ATRC
$1.84B
| $27.6M | 4.17% | 1,105,709 -6,031 | -0.5% | -$150K |
|
7
Halozyme
HALO
$8.56B
| $26.1M | 3.95% | 1,682,745 +614,932 | +58% | +$9.54M |
|
8
NeoGenomics
NEO
$1.13B
| $25.2M | 3.81% | 1,319,746 -5,836 | -0.4% | -$112K |
|
|
9
Insmed
INSM
$28.8B
| $22.8M | 3.45% | +1,294,743 | New | +$22.8M |
|
|
SPNE
10
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $22.6M | 3.42% | 1,852,556 +51,559 | +3% | +$630K |
|
|
XENT
11
DELISTED
Intersect ENT, Inc
XENT
| $20.7M | 3.13% | 1,216,122 +547,229 | +82% | +$9.31M |
|
|
PTLA
12
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $20.5M | 3.1% | +764,096 | New | +$20.5M |
|
13
Heron Therapeutics
HRTX
$207M
| $20.2M | 3.05% | 1,091,110 -7,613 | -0.7% | -$141K |
|
14
Ionis Pharmaceuticals
IONS
$6.79B
| $19.5M | 2.94% | 324,649 -2,483 | -0.8% | -$149K |
|
|
IMMU
15
DELISTED
Immunomedics Inc
IMMU
| $16.6M | 2.51% | 1,250,536 +27,053 | +2% | +$359K |
|
16
Codexis
CDXS
$246M
| $16.4M | 2.48% | 1,198,452 -7,071 | -0.6% | -$97K |
|
|
AMRN
17
Amarin Corp
AMRN
$311M
| $13.9M | 2.11% | +918,846 | New | +$13.9M |
|
18
SI-BONE Inc
SIBN
$719M
| $11.4M | 1.73% | 645,982 -5,337 | -0.8% | -$94.3K |
|
19
Xencor
XNCR
$580M
| $11.3M | 1.71% | 335,444 -163,900 | -33% | -$5.53M |
|
|
ELGX
20
DELISTED
Endologix Inc
ELGX
| $11.3M | 1.71% | 2,844,317 +381,869 | +16% | +$1.52M |
|
21
Agios Pharmaceuticals
AGIO
$2.19B
| $10.8M | 1.63% | 332,442 +84,545 | +34% | +$2.74M |
|
|
TRHC
22
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $10.7M | 1.62% | +195,347 | New | +$10.7M |
|
23
Veracyte
VCYT
$2.39B
| $9.86M | 1.49% | 410,925 -178,174 | -30% | -$4.28M |
|
|
VAPO
24
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $9.7M | 1.47% | 1,023,734 +526,765 | +106% | +$4.99M |
|
|
ARNA
25
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $8.74M | 1.32% | 190,838 +146,134 | +327% | +$6.69M |
|